March 23, 2020 / 2:43 PM / 9 days ago

BRIEF-Scandion Oncology: Clinical Development Plans For SCO-101

March 23 (Reuters) - Scandion Oncology A/S:

* CLINICAL DEVELOPMENT PLANS FOR SCO-101

* HAS TOGETHER WITH ITS CLINICAL PARTNERS AT HOSPITALS DECIDED TO CONTINUE COLORECTAL CANCER STUDY WITH FOLFIRI RESISTANT PATIENTS

* IS NOT ABLE TO PREDICT HOW MANY PATIENTS THAT WILL BE INCLUDED IN NEXT COUPLE OF MONTHS Source text for Eikon: Further company coverage: (Gdansk Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below